Pfizer winds up Baxter acquisition
The Hungarian unit of U.S. drugmaker Pfizer closed the takeover of the vaccine portfolio of peer Baxter Hungary on January 1, the company announced yesterday.
The parent company announced on December 1 that it completed the acquisition of Baxter on. Pfizer's revenue in Hungary reached almost HUF 30 bln in 2013.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.